Equity
€107,509 from €225,423 in 2023
Equity fell by 52% in 2 years.
PLASTHEA
Lifetime
5 annual accounts with figures on one time axispeak €193,090 (2025)
€193,090▲ 32.2%
peak €134,676 (2022)
€123,344▲ 39.0%
peak €225,423 (2023)
€107,509▼ 5.8%
€126,184▲ 78.4%
Board2 names since 2021
1 director
Documentsfilings and deeds
31-08-202631 days late
2025abbreviated format
Gross margin from €146,048 to €193,090Result from €88,742 to €123,344Dividend €100,000Debts from €70,745 to €126,184
Key points
from the 2025 annual accountsTurnover
≈ €360,000 estimated
The accounts state no turnover.
Debts
€126,184 ▲ 78.4%
Debts rose by €55,439 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.
Filings
5 annual accounts 5 late
The 2025 accounts came latest: 31 days after the end of the period.
Starting capital
€2,000 100 shares
Board
1 joined
New director. Latest change 01-07-2026 · 2 in office.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 26,973 companies had the same profile as PLASTHEA has now. Each dot stands for 68 companies, two years later.
94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 26,973 companies, not a prediction for PLASTHEA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Appointment: (director)
General meeting of 20-07-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0774860051
First establishment
Clos du Vannier 9, Chaudfontaine
Incorporation
Founding capital of €2,000, 100 shares · Founder: · Appointment: (director) · published on 04-10-2021 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| PLASTHEA Chaudfontaine | €233,693 | €193,090 | 46.0% | - |
| DOCTEUR CECILE ANDRIS Huy | €228,260 | €198,117 | 47.9% | - |
| DOCTEUR MARTIN MOÏSE Esneux | €229,059 | €220,077 | 30.0% | - |
| dr. K. Reekmans, neurologie Herk-de-Stad | €228,709 | €187,713 | 70.9% | - |
| Dr. Katrien Raes, Fysische Geneeskunde en Revalidatie Affligem | €230,581 | €177,366 | 40.8% | - |
| Dr. Kris Gillis Roeselare | €238,082 | €212,195 | 0.4% | - |
| DR. ELINE VAN HOVE Bertem | €231,000 | €212,556 | 41.6% | - |
These companies have the same main activity as PLASTHEA: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €228,000 and €238,000, founded between 2021 and 2022.
Official details
Source: KBO- Status
- Active since 30-09-2021Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.322.934.2244053 Chaudfontaine, since 01-10-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 17-10-2025
Insights on PLASTHEA
PLASTHEA files the abbreviated format. That format states no turnover. The gross margin rose from €24,032 in 2021 to €193,090 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about PLASTHEA
- What is the company number of PLASTHEA?
- The company number of PLASTHEA is 0774.860.051. The VAT number is the same number with BE in front: BE 0774.860.051.
- Where is PLASTHEA based?
- The registered office is at Clos du Vannier 9, 4053 Chaudfontaine.Company details
- What does PLASTHEA do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of PLASTHEA?
- PLASTHEA is a private limited company (BV).
- When was PLASTHEA founded?
- PLASTHEA was founded on 30-09-2021.
- Is PLASTHEA still active?
- Yes, PLASTHEA is an active enterprise in the KBO register.
- What is the turnover of PLASTHEA?
- The turnover in financial year 2025 is ≈ €360,000. This figure is estimated from the gross margin of €193,090 and 40 comparable companies (NACE 86220). It probably lies between €300,000 and €480,000.Financials
- Is PLASTHEA profitable?
- In financial year 2025, PLASTHEA made a profit of €123,344.
- Where can I find the annual accounts of PLASTHEA?
- PLASTHEA filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PLASTHEA due?
- PLASTHEA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.